The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Breast Cancer Screen 35 Tissue Microarray - LS-SBRCA35

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SBRCA35
Product Name:	Breast Cancer Screen 35
Description:	Breast cancer with matched adjacent normal/non-neoplastic, metastatic lymph nodes, and marker data
Format:	FFPE
Category:	Human Tumor and Matched Normal
QA/QC:	H&E reviewed; IHC validated with a positive control antibody
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	Yes
Stage/Grade:	Yes
Core Diameter:	1.5 mm
Core Thickness:	5 µm
Cases:	45
Cores:	46
Slides Per Set:	1

LS-SBRCA35 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9
A	Bst	Bst	Lym	Bst	Ova	Bst	Bst	Bst	Bst
B	Bst	Bst	Lym	Bst	Lym	Bst	Bst	Bst	Bst
C	Bst	Bst	Lym	Bst	Lym	Bst	Bst	Bst	Bst
D	Bst	Bst	Lym	Bst	Lym	Bst	Bst	Bst	Bst
E	Bst	Bst	Lym	Bst	Lym	Bst	Bst	Bst	Bst
F	Unk

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Breast (Bst); Lymph node (Lym); Ovary (Ova); Unknown (Unk);

LS-SBRCA35 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	Estrogen Receptor (ER)	Progesterone Receptor (PR)	Tumor Suppressor p53 (p53)	Positive Lymph Nodes	TNM Tumor Classification	Tumor Grade
1	A1	Human	F	47 y	Breast (Bst)	Normal	Benign non-neoplastic
1	A2	Human	F	43 y	Breast (Bst)	Normal	Benign non-neoplastic
1	A3	Human	F	55 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				3/21	T2
1	A4	Human	F	55 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+	3/21	T2
1	A5	Human	F	37 y	Ovary (Ova)	Metastatic adenocarcinoma	Metastatic				23/23	TxNxM1
1	A6	Human	F	46 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	-	-	0/17	T2
1	A7	Human	F	54 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	+	-	0/17	T2
1	A8	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	+	-	0/22	T2	2
1	A9	Human	F	43 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+	0/13	T2	3
1	B1	Human	F	53 y	Breast (Bst)	Normal	Benign non-neoplastic
1	B2	Human	F	51 y	Breast (Bst)	Normal	Benign non-neoplastic
1	B3	Human	M	66 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				5/14	T1c
1	B4	Human	M	66 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	5/14	T1c
1	B5	Human	F	35 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				8/14	T3
1	B6	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	-	-	8/14	T3
1	B7	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+	8/17	T2
1	B8	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+	0/12	T2	2
1	B9	Human	F	51 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	+	-	0/20	T2
1	C1	Human	F	59 y	Breast (Bst)	Normal	Benign non-neoplastic
1	C2	Human	F	36 y	Breast (Bst)	Normal	Benign non-neoplastic
1	C3	Human	F	42 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				4/18	T2
1	C4	Human	F	42 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant				4/18	T2
1	C5	Human	F	52 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				24/24	T3
1	C6	Human	F	52 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant				24/24	T3
1	C7	Human	F	41 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	+	-	0/6	T3
1	C8	Human	F	59 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	-	-	3/24	T2	2
1	C9	Human	F	36 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	7/24	T2	3
1	D1	Human	F	37 y	Breast (Bst)	Normal	Benign non-neoplastic
1	D2	Human	F	59 y	Breast (Bst)	Normal	Benign non-neoplastic
1	D3	Human	F	44 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				1/12	T3
1	D4	Human	F	44 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	-	+	1/12	T3
1	D5	Human	F	35 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				6/10	T3
1	D6	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant				6/10	T3
1	D7	Human	F	38 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+	2/6	T3
1	D8	Human	F	60 y	Breast (Bst)	Signet ring cell carcinoma	Malignant	+	+	-	0/7	T3
1	D9	Human	F	59 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	+	-	16/25	T2	2
1	E1	Human	F	37 y	Breast (Bst)	Normal	Benign non-neoplastic
1	E2	Human	F	57 y	Breast (Bst)	Normal	Benign non-neoplastic
1	E3	Human	F	37 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				7/21	T3	3
1	E4	Human	F	37 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+	+	7/21	T3	3
1	E5	Human	F	48 y	Lymph node (Lym)	Metastasis from breast carcinoma	Metastatic				38/38	T3
1	E6	Human	F	48 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant				38/38	T3
1	E7	Human	F	65 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	-	-	0/9	T2
1	E8	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	+	0/26	T2
1	E9	Human	F	57 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+	+	+	8/8	T3	2
1	F1	Human	U		Unknown (Unk)	Unknown	Unknown

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.